ARCHIVES

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 27 | July 8, 2011

Download PDF Visit The Full Archive

Related Articles

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

DeVita Considers Laetrile Tests

June 3, 1977

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004